Tanzania is using its participation in the 2026 International Convention and Exhibition on Pharmaceutical Industries, Medical Devices, Vaccines and Laboratory Reagents (CPHI) in Milan, Italy, to attract investment that could strengthen local production of medicines and other essential health products.
The three-day event, running from October 6 to 8, brings together players in the global pharmaceutical and medical-products industry, providing Tanzania with an opportunity to showcase investment opportunities and seek partnerships in the production of medicines, medical devices, vaccines and laboratory reagents.
The Tanzanian delegation is participating under the Pharmaceutical and Medical Devices Investment Acceleration Task Force (PIAT) and is led by the Deputy Permanent Secretary in the Ministry of Health responsible for Medicines and Medical Devices, Emmanuel Tayari.
Tayari said Tanzania’s participation has opened opportunities for the country to engage directly with investors and international stakeholders, with the aim of attracting both domestic and foreign investment into the health-products industry.
He said increased investment in local manufacturing would help Tanzania expand its capacity to produce essential health products domestically while creating opportunities for partnerships, technology transfer and skills development.
The initiative is particularly significant for citizens as stronger domestic production could help improve the availability of medicines and medical supplies and reduce the country’s reliance on imports.
Tayari said Tanzania is also seeking to promote opportunities for investors in the production of medicines, medical devices, vaccines and laboratory reagents, while strengthening cooperation with international stakeholders.
Beyond improving access to health products, greater investment in local pharmaceutical manufacturing could contribute to job creation and support the growth of related industries, including research, packaging, logistics and distribution.
Tayari said the efforts support the implementation of Tanzania’s Development Vision 2050 by increasing domestic production, reducing dependence on imported health products and strengthening the country’s capacity to provide safe, effective and quality health products to its people.
The government’s participation in CPHI Milan therefore signals an effort to turn Tanzania’s growing healthcare needs into opportunities for local manufacturing, investment and improved access to essential health products for citizens.